Insider Trading activities of Nastech Pharmaceutical Co Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nastech Pharmaceutical Co Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nastech Pharmaceutical Co Inc since year 2005. Table 2 shows the detailed insider transactions of Nastech Pharmaceutical Co Inc since 2005. The reporting company's ticker symbol is MRNA. The reporting company's CIK number is 737207.
The total value of stock buying since 2005 is $819,213.
The total value of stock sales since 2005 is $5,938,925.
The total value of stock option exercises since 2005 is $1,948,393.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Nastech Pharmaceutical Co Inc (MRNA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 32,500 $12,650 0 $0 0 $0
2017-04 133,050 $44,365 0 $0 0 $0
2017-02 862,068 $249,999 0 $0 0 $0
2014-04 26,300 $19,988 0 $0 0 $0
2014-02 0 $0 108,041 $106,986 0 $0
2013-10 0 $0 100,000 $24,645 0 $0
2011-01 0 $0 449,705 $561,235 0 $0
2008-08 10,000 $7,610 0 $0 0 $0
2008-07 0 $0 752 $847 0 $0
2008-05 60,000 $71,549 0 $0 0 $0
2008-03 5,000 $11,975 0 $0 0 $0
2007-12 2,000 $8,080 0 $0 0 $0
2007-11 0 $0 3,000 $43,722 0 $0
2007-10 0 $0 4,500 $64,714 0 $0
2007-09 0 $0 59,600 $846,927 57,316 $565,995
2007-08 0 $0 35,558 $510,624 35,351 $330,884
2007-07 0 $0 8,800 $105,939 0 $0
2007-06 0 $0 9,400 $107,092 0 $0
2007-05 0 $0 3,000 $40,980 0 $0
2007-04 0 $0 11,850 $147,263 5,000 $54,950
2007-03 12,000 $124,662 1,000 $11,197 0 $0
2007-02 0 $0 12,130 $149,222 5,000 $48,200
2007-01 0 $0 13,456 $191,012 5,000 $44,450
2006-12 2,200 $34,577 8,675 $146,576 5,000 $54,950
2006-11 0 $0 11,620 $205,848 5,000 $54,950
2006-10 3,000 $47,250 13,836 $214,118 5,000 $54,950
2006-09 0 $0 6,000 $90,644 5,000 $54,950
2006-08 0 $0 12,702 $175,950 5,000 $50,450
2006-07 0 $0 6,700 $103,739 5,000 $44,450
2006-06 0 $0 27,460 $387,789 25,000 $209,450
2006-05 3,000 $39,390 8,500 $121,966 5,000 $44,450
2006-04 0 $0 13,767 $227,965 2,667 $26,083
2006-03 5,000 $84,315 27,402 $505,805 14,167 $116,711
2006-02 0 $0 13,700 $260,715 10,000 $82,100
2006-01 0 $0 18,000 $264,463 10,000 $64,170
2005-12 0 $0 13,000 $198,302 10,000 $46,250
2005-11 0 $0 1,000 $13,043 0 $0
2005-10 0 $0 1,000 $14,119 0 $0
2005-09 0 $0 1,000 $13,889 0 $0
2005-08 0 $0 1,000 $14,597 0 $0
2005-07 0 $0 1,000 $14,190 0 $0
2005-06 0 $0 2,225 $28,354 0 $0
2005-05 0 $0 1,000 $10,392 0 $0
2005-04 4,300 $43,803 1,000 $10,056 0 $0
2005-03 2,000 $19,000 400 $4,000 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Nastech Pharmaceutical Co Inc insiders (MRNA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-09 Trieu Vuong (Chairman of the Board) Buy 10,000 .39 3,900
2017-06-08 Trieu Vuong (Chairman of the Board) Buy 20,000 .39 7,800
2017-06-07 Trieu Vuong (Chairman of the Board) Buy 2,500 .38 950
2017-04-07 Ramelli Joseph W. (Chief Executive Officer) Buy 22,500 .42 9,562
2017-04-06 Ramelli Joseph W. (Chief Executive Officer) Buy 13,000 .34 4,368
2017-04-05 Ramelli Joseph W. (Chief Executive Officer) Buy 97,550 .31 30,435
2017-02-06 Trieu Vuong (Chairman of the Board) Buy 862,068 .29 249,999
2014-04-16 Ramelli Joseph W. (Director) Buy 26,300 .76 19,988
2014-02-10 Pryor Cashman Llp (10% Owner) Sale 15,000 1.02 15,270
2014-02-07 Pryor Cashman Llp (10% Owner) Sale 59,000 1.01 59,412
2014-02-06 Pryor Cashman Llp (10% Owner) Sale 34,041 .95 32,304
2013-10-04 Pryor Cashman Llp (10% Owner) Sale 35,000 .24 8,330
2013-10-03 Pryor Cashman Llp (10% Owner) Sale 65,000 .25 16,315
2011-01-26 Novartis Ag (10% Owner) Sale 74,500 1.15 85,302
2011-01-25 Novartis Ag (10% Owner) Sale 93,005 1.14 105,932
2011-01-24 Novartis Ag (10% Owner) Sale 72,800 1.19 86,704
2011-01-21 Novartis Ag (10% Owner) Sale 69,500 1.26 87,917
2011-01-20 Novartis Ag (10% Owner) Sale 51,400 1.40 68,959
2011-01-19 Novartis Ag (10% Owner) Sale 42,800 1.54 65,869
2008-08-11 French J Michael (CEO) Buy 10,000 .76 7,610
2008-07-14 Costantino Henry R (CSO - Delivery) Sale 231 1.01 233
2008-07-02 Costantino Henry R (CSO - Delivery) Sale 240 1.17 280
2008-07-01 Costantino Henry R (CSO - Delivery) Sale 81 1.19 96
2008-07-01 Duffy Timothy M (Chief Business Officer) Sale 200 1.19 238
2008-05-13 Thaw Bruce R/fa (Director) Buy 50,000 1.20 60,150
2008-05-12 Stanewick Gerald T (Director) Buy 10,000 1.14 11,399
2008-03-19 Stanewick Gerald T (Director) Buy 5,000 2.40 11,975
2007-12-07 York Bruce R (Chief Actg Officer, Asst Sec.) Buy 2,000 4.04 8,080
2007-11-01 Wenig Devin (Director) Sale 3,000 14.57 43,722
2007-10-09 Wenig Devin (Director) Sale 1,500 16.02 24,037
2007-10-01 Wenig Devin (Director) Sale 3,000 13.56 40,677
2007-09-27 Quay Steven C (Chairman, President and CEO) Sale 5,200 13.57 70,564
2007-09-10 Stanewick Gerald T (Director) Sale 4,200 14.21 59,694
2007-09-06 Johnson Paul H (Sr VP of R&D, CSO) Sale 47,200 14.30 674,960
2007-09-06 Johnson Paul H (Sr VP of R&D, CSO) Option Ex 57,316 9.88 565,995
2007-09-04 Wenig Devin (Director) Sale 3,000 13.90 41,709
2007-08-23 Johnson Paul H (Sr VP of R&D, CSO) Sale 1,100 14.30 15,733
2007-08-23 Johnson Paul H (Sr VP of R&D, CSO) Option Ex 1,339 9.36 12,533
2007-08-22 Johnson Paul H (Sr VP of R&D, CSO) Sale 20,558 14.30 293,979
2007-08-22 Johnson Paul H (Sr VP of R&D, CSO) Option Ex 28,058 9.36 262,622
2007-08-21 Johnson Paul H (Sr VP of R&D, CSO) Sale 3,900 14.50 56,550
2007-08-21 Johnson Paul H (Sr VP of R&D, CSO) Option Ex 5,954 9.36 55,729
2007-08-15 Holubiak Myron Z (Director) Sale 3,000 14.19 42,567
2007-08-08 Wenig Devin (Director) Sale 4,000 16.00 64,019
2007-08-01 Wenig Devin (Director) Sale 3,000 12.59 37,776
2007-07-25 Quay Steven C (Chairman, President and CEO) Sale 5,800 12.23 70,963
2007-07-10 Wenig Devin (Director) Sale 2,000 12.02 24,040
2007-07-02 Wenig Devin (Director) Sale 1,000 10.94 10,936
2007-06-07 Quay Steven C (Chairman, President and CEO) Sale 6,400 11.05 70,720
2007-06-01 Wenig Devin (Director) Sale 3,000 12.12 36,372
2007-05-07 Wenig Devin (Director) Sale 3,000 13.66 40,980
2007-04-20 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 13.22 66,105
2007-04-20 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 10.99 54,950
2007-04-18 Quay Steven C (Chairman, President and CEO) Sale 5,850 12.04 70,410
2007-04-02 Wenig Devin (Director) Sale 1,000 10.75 10,748
2007-03-09 Beese J Carter Jr (Director) Buy 8,000 10.21 81,696
2007-03-08 Stanewick Gerald T (Director) Buy 2,000 10.73 21,466
2007-03-08 Beese J Carter Jr (Director) Buy 2,000 10.75 21,500
2007-03-01 Wenig Devin (Director) Sale 1,000 11.20 11,197
2007-02-27 Quay Steven C (Chairman, President and CEO) Sale 6,130 11.50 70,519
2007-02-07 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 13.12 65,595
2007-02-07 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 9.64 48,200
2007-02-01 Wenig Devin (Director) Sale 1,000 13.11 13,108
2007-01-25 Quay Steven C (Chairman, President and CEO) Sale 5,250 13.43 70,486
2007-01-04 Ranker Philip C (Chief Financial Officer) Sale 2,206 14.58 32,163
2007-01-04 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 14.69 73,465
2007-01-04 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 8.89 44,450
2007-01-03 Wenig Devin (Director) Sale 1,000 14.90 14,898
2006-12-22 Brandt Gordon (Exec VP of Science and Clinica) Sale 675 15.67 10,577
2006-12-11 Stanewick Gerald T (Director) Buy 1,423 15.67 22,301
2006-12-08 Stanewick Gerald T (Director) Buy 777 15.80 12,276
2006-12-05 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 16.18 80,910
2006-12-05 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 10.99 54,950
2006-12-01 Wenig Devin (Director) Sale 3,000 18.36 55,089
2006-11-15 Quay Steven C (Chairman, President and CEO) Sale 3,620 19.56 70,818
2006-11-03 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 16.45 82,260
2006-11-03 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 10.99 54,950
2006-11-01 Wenig Devin (Director) Sale 3,000 17.59 52,770
2006-10-10 Wenig Devin (Director) Sale 2,000 16.00 32,000
2006-10-09 Quay Steven C (Chairman, President and CEO) Sale 5,175 15.62 80,807
2006-10-06 Stanewick Gerald T (Director) Buy 3,000 15.75 47,250
2006-10-05 Johnson Paul H (Sr VP of R&D, CSO) Sale 661 15.54 10,271
2006-10-04 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 15.14 75,705
2006-10-04 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 10.99 54,950
2006-10-02 Wenig Devin (Director) Sale 1,000 15.34 15,335
2006-09-06 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 15.10 75,520
2006-09-06 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 10.99 54,950
2006-09-01 Wenig Devin (Director) Sale 1,000 15.12 15,124
2006-08-11 York Bruce R (Other) Sale 882 14.23 12,550
2006-08-08 Quay Steven C (Chairman, President and CEO) Sale 5,820 13.88 80,764
2006-08-03 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 13.85 69,260
2006-08-03 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 10.09 50,450
2006-08-01 Wenig Devin (Director) Sale 1,000 13.38 13,376
2006-07-06 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 15.43 77,125
2006-07-06 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 8.89 44,450
2006-07-05 Wenig Devin (Director) Sale 500 16.00 8,000
2006-07-03 Duffy Timothy M (Exec. VP of Business Devp) Sale 200 15.58 3,116
2006-07-03 Wenig Devin (Director) Sale 1,000 15.50 15,498
2006-06-28 Duffy Timothy M (Exec. VP of Business Devp) Sale 1,460 14.81 21,622
2006-06-08 Wenig Devin (Director) Sale 2,000 13.68 27,360
2006-06-08 Wenig Devin (Director) Option Ex 2,000 8.25 16,500
2006-06-07 Thaw Bruce R/fa (Director) Sale 10,000 14.00 140,000
2006-06-07 Thaw Bruce R/fa (Director) Option Ex 10,000 8.25 82,500
2006-06-05 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 14.81 74,045
2006-06-05 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 8.89 44,450
2006-06-05 Wenig Devin (Director) Sale 8,000 13.84 110,736
2006-06-05 Wenig Devin (Director) Option Ex 8,000 8.25 66,000
2006-06-01 Wenig Devin (Director) Sale 1,000 14.03 14,026
2006-05-26 Wormuth David E (Sr VP, Operations & Mfg) Sale 2,500 13.58 33,955
2006-05-16 Michelson Leslie D (Director) Buy 3,000 13.13 39,390
2006-05-11 Brandt Gordon (Exec VP of Science and Clinica) Sale 5,000 14.57 72,850
2006-05-11 Brandt Gordon (Exec VP of Science and Clinica) Option Ex 5,000 8.89 44,450
2006-05-01 Wenig Devin (Director) Sale 1,000 15.16 15,161
2006-04-25 Quay Steven C (Chairman, President and CEO) Sale 5,100 15.75 80,345
2006-04-11 Quay Steven C (Chairman, President and CEO) Sale 2,667 15.83 42,218
2006-04-11 Quay Steven C (Chairman, President and CEO) Option Ex 2,667 9.78 26,083
2006-04-05 Stanewick Gerald T (Director) Sale 3,000 17.25 51,750
2006-04-03 Wenig Devin (Director) Sale 3,000 17.88 53,652
2006-03-29 Pollock John V (Director) Sale 10,000 17.86 178,590
2006-03-28 Pollock John V (Director) Option Ex 10,000 8.25 82,500
2006-03-27 Brandt Gordon (Exec VP of Science and Clinica) Sale 1,685 18.34 30,902
2006-03-22 Wormuth David E (Sr VP, Operations & Mfg) Sale 4,167 16.75 69,805
2006-03-22 Wormuth David E (Sr VP, Operations & Mfg) Option Ex 4,167 8.21 34,211
2006-03-22 Michelson Leslie D (Director) Buy 5,000 16.86 84,315
2006-03-16 Quay Steven C (Chairman, President and CEO) Sale 4,950 16.17 80,041
2006-03-01 Wenig Devin (Director) Sale 6,600 22.19 146,467
2006-02-23 Wenig Devin (Director) Sale 3,600 20.19 72,669
2006-02-22 Wormuth David E (Sr VP, Operations & Mfg) Sale 10,000 18.70 186,167
2006-02-22 Wormuth David E (Sr VP, Operations & Mfg) Option Ex 10,000 8.21 82,100
2006-01-27 Wenig Devin (Director) Sale 2,000 16.00 32,000
2006-01-23 Wormuth David E (Sr VP, Operations &) Sale 10,000 14.58 145,780
2006-01-23 Wormuth David E (Sr VP, Operations &) Option Ex 10,000 6.42 64,170
2006-01-03 Wenig Devin (Director) Sale 1,000 14.61 14,608
2005-12-22 Wormuth David E (Sr VP, Operations &) Sale 10,000 15.19 151,940
2005-12-22 Wormuth David E (Sr VP, Operations &) Option Ex 10,000 4.62 46,250
2005-12-07 Wenig Devin (Director) Sale 2,000 16.03 32,060
2005-12-01 Wenig Devin (Director) Sale 1,000 14.30 14,302
2005-11-01 Wenig Devin (Director) Sale 1,000 13.04 13,043
2005-10-03 Wenig Devin (Director) Sale 1,000 14.12 14,119
2005-09-01 Wenig Devin (Director) Sale 1,000 13.89 13,889
2005-08-01 Wenig Devin (Director) Sale 1,000 14.60 14,597
2005-07-01 Wenig Devin (Director) Sale 1,000 14.19 14,190
2005-06-16 Duffy Timothy M (VP of Business Devp) Sale 1,225 13.24 16,219
2005-06-01 Wenig Devin (Director) Sale 1,000 12.13 12,135
2005-05-02 Wenig Devin (Director) Sale 1,000 10.39 10,392
2005-04-14 Michelson Leslie D (Director) Buy 3,000 10.29 30,869
2005-04-06 Wenig Devin (Director) Sale 1,000 10.06 10,056
2005-04-04 Stanewick Gerald T (Director) Buy 1,300 9.95 12,934
2005-03-18 Stanewick Gerald T (Director) Buy 2,000 9.50 19,000
2005-03-10 Wenig Devin (Director) Sale 400 10.00 4,000

Insider trading activities including stock purchases, stock sales, and option exercises of MRNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nastech Pharmaceutical Co Inc (symbol MRNA, CIK number 737207) see the Securities and Exchange Commission (SEC) website.